ARCHIVES

William Tipping New ACS Executive VP; Murphy To Replace Holleb, Laszio Takes Rauscher’s Position

This article is from The Cancer Letter archive.

Vol. 14 No. 10 | March 4, 1988

Download PDF Visit The Full Archive

Related Articles

Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial

January 31, 2014

House Appropriations by Institute

July 8, 1994

Bevacizumab And Irinotecan May Increase Survival Of GBM

October 26, 2007

NCA Uneasy Over Possible NIH Takeover Of FCRC, But It Won’t Happen

June 13, 1980

NIH Draft Guidelines On Stem Cell Research Limit Funds To Cells From In Vitro Fertilization

April 24, 2009

Campus-Dweller Rabson Finds Comfort In NIH Security.

December 14, 2001